COVID-19 Updates: Cases Cross 94.62 Lakh-Mark In India on Tuesday, December 1
The COVID-19 tally of India has reached 94,62,810 on Tuesday, December 1 after addition of around 31,118 new cases.
The COVID-19 tally of India has reached 94,62,810 on Tuesday, December 1. A spike of around 31,118 new cases was reported just in the last 24 hours. Along with it, 482 death reports were also registered. Currently, there are around 4,35,603 active cases in the country. Meanwhile, recovered numbers have reached 88,89,585 out of which 41,985 were discharged in the last 24 hours. Reports also claim that a significant dip in the numbers of COVID-19 cases has been observed. Take a look at it here:
COVID-19 vaccine update:
The pharmaceutical giant Pfizer on November 9 announced that their mRNA-based vaccine candidate namely BNT162b2 has demonstrated evidence of efficacy against the COVID-19 virus in the final analysis of the Phase 3 trial. The drugmaker claims that the vaccine was consistent across age and ethnicity demographics. Adding to the same, their press release also suggests that no major side effects were observed.
ALSO READ| COVID-19: Cases Cross 83 Lakh-Mark In India
The analysis was done based on the study conducted on 170 confirmed case of COVID-19. The vaccine candidate BNT162b2 showed 95% efficacy beginning 28 days after the first dose, the giant said. This means that the protection is achieved 28 days after initiation of the vaccination, which consists of a 2-dose schedule, as per their website. As the study continues, the efficacy of the vaccine percentage may tend to vary.
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen. With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”
Watch latest news only on ZEE5